ADVFN US – Market Content Editor

  • Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances

    Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances

    Bone Biologics has extended the validated shelf life of its rhNELL-1 protein to 32 months, giving the company greater manufacturing and supply-chain flexibility as it prepares for larger-scale clinical development and advances enrollment in its first-in-human NB1 study. Key Investor Takeaways Why (NASDAQ:BBLG) Stock Is in Focus Bone Biologics has validated a 32-month shelf life…

  • Zhibao Technology Forms AI-Native Long-Term Insurance Joint Venture With Dongbaohui

    Zhibao Technology Forms AI-Native Long-Term Insurance Joint Venture With Dongbaohui

    Zhibao Technology has signed an agreement with Dongbaohui to establish a joint venture focused on AI-native embedded long-term insurance, adding a new strategic growth initiative alongside its existing 2B2C digital insurance business. Key Investor Takeaways Why ZBAO Stock Is in Focus Zhibao Technology is expanding its business model into long-term insurance through a newly agreed…

  • SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product

    SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product

    SCIENTURE has commercially launched REZENOPY, its 10 mg naloxone nasal spray, and fulfilled initial purchase orders to U.S. pharmaceutical wholesalers, moving its second FDA-approved commercial product into nationwide distribution. Key Investor Takeaways Why SCNX Stock Is in Focus SCIENTURE has fulfilled its first REZENOPY purchase orders to U.S. pharmaceutical wholesalers and commenced nationwide distribution, marking…

  • Intuit Expands Conversational AI Across Mid-Market Finance Platform

    Intuit Expands Conversational AI Across Mid-Market Finance Platform

    Intuit is rolling out Intuit Intelligence Chat and broader AI-powered financial capabilities across QuickBooks Online Advanced and Intuit Enterprise Suite, strengthening its push into more complex mid-market finance workflows. Key Investor Takeaways Why INTU Stock Is in Focus Intuit is expanding Intuit Intelligence across QuickBooks Online Advanced and Intuit Enterprise Suite, with Intuit Intelligence Chat…

  • Stanley Black & Decker outlines $1 billion U.S. investment through 2028

    Stanley Black & Decker outlines $1 billion U.S. investment through 2028

    Stanley Black & Decker (NYSE:SWK) plans to invest $1 billion across its U.S. operations through 2028, with spending focused on research and development, manufacturing capabilities and workforce development. The New Britain, Connecticut-based company said the programme is intended to support the development of new products while strengthening its domestic manufacturing infrastructure and preparing workers for…

  • Similarweb shares surge after earnings beat and upgraded 2026 outlook

    Similarweb shares surge after earnings beat and upgraded 2026 outlook

    Similarweb Ltd. (NYSE:SMWB) shares jumped 17% in premarket trading on Wednesday after the digital data and analytics company reported second-quarter earnings and revenue above Wall Street expectations and raised its full-year guidance amid strong demand for AI-related solutions. Adjusted earnings per share came in at $0.06, double the analyst consensus estimate of $0.03. Revenue increased…

  • NeOnc Technologies shares jump after positive Phase 2a glioma results

    NeOnc Technologies shares jump after positive Phase 2a glioma results

    NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) shares climbed 11.7% after the biotechnology company announced positive topline results from a Phase 2a study evaluating intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma. The trial achieved its primary endpoint, with six-month progression-free survival reaching 48.9%. That compared with a pre-specified standard-of-care benchmark of 20%, with the result…

  • Neurocrine Biosciences shares fall amid Vykat safety concerns

    Neurocrine Biosciences shares fall amid Vykat safety concerns

    Neurocrine Biosciences (NASDAQ:NBIX) shares dropped 5.8% following reports of patient deaths and serious adverse events potentially associated with Vykat, a treatment for Prader-Willi syndrome. According to Stat News, physicians and experts specialising in the rare condition alerted clinicians to several deaths and severe side effects reported among patients who had been prescribed the drug. Prader-Willi…

  • Home Depot CEO Ted Decker begins temporary medical leave

    Home Depot CEO Ted Decker begins temporary medical leave

    Home Depot (NYSE:HD) announced that chair, president and chief executive officer Ted Decker is taking a temporary medical leave of absence, with the retailer expecting him to return to his duties within the next few months. The company has put an interim leadership structure in place to oversee operations and financial management while Decker is…

  • U.S. CPI rises 0.1% in July, matching market expectations

    U.S. CPI rises 0.1% in July, matching market expectations

    U.S. consumer prices increased by 0.1% in July, exactly in line with economists’ forecasts, providing investors with fresh evidence that inflationary pressures remained relatively contained during the month. The Consumer Price Index is one of the most closely followed measures of inflation in the United States, offering insight into changes in household costs and broader…